10x Genomics
TXG Healthcare Health Information Services
10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024. In the quarter to June 2026, revenue fell 12.7%, EPS fell 150.0% and free cash flow fell 4.61%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow TXG
10x Genomics (TXG) EV/Sales
As of 16 October 2026, 10x Genomics (TXG) trades at a EV/Sales of 13.9×. Over the past ten years it has ranged from 0.0× (December 2019) to 64.5× (February 2021); the current reading is higher than 67% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.4× | 7.19% |
| FY2024 | 2.2× | (76.95%) |
| FY2023 | 9.7× | 38.42% |
| FY2022 | 7.0× | (78.35%) |
| FY2021 | 32.4× | (29.24%) |
| FY2020 | 45.8× | 62.39% |
| FY2019 | 28.2× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 7.2× | 108.69% |
| Mar 2026 | 3.5× | 44.55% |
| Dec 2025 | 2.4× | 51.62% |
| Sep 2025 | 1.6× | 0.34% |
| 26 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 1.0× |
| PRVA Privia Health Group, Inc. compare | 1.0× |
| WAY Waystar Holding Corp. compare | 5.4× |
| HQY HealthEquity, Inc. compare | 6.1× |
| DOCS Doximity, Inc. compare | 7.6× |
| TEM Tempus AI, Inc. compare | 8.5× |
| HNGE Hinge Health Inc. compare | 10.3× |
| TXG 10x Genomics | 13.9× |
| HTFL Heartflow, Inc. compare | 19.8× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)